Course/Event Date: Friday, April 29, 2022
Course/Event Duration: 1 Day
Recognition of kidney disease has risen dramatically in recent years and almost 1 in 10 people have some form of renal disease. This symposium offers an overview of latest developments in the diagnosis and management of kidney disorders including the reno-protective effects of SGLT2 inhibitors and how cutting edge genetic science is applied to renal disease. We will review optimising risk stratification of chronic kidney disease, new therapeutics for anaemia of renal disease and the evolving management of glomerulonephritis plus point of care diagnostics and interventional nephrology. The keynote lecture will explore the impact the Covid-19 pandemic has had on the uniquely vulnerable group of people who have severe renal disease and the professionals who care for them.
The morning session will appeal to students, doctors in training, and a broad range of clinicians in primary and secondary care while the afternoon session is more specifically relevant to the multi-professional kidney team. Half day or full day registration is available. By attending this symposium, you will keep up-to-date with the fast moving developments in nephrology.
Course/Event Venue: Royal College of Physicians Edinburgh and online
This course is targeted at the following specialty Groupings:
